Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs)
$104.24
pos +2.06
+2.02%
Today's Range: 102.45 - 104.68 | AMGN Avg Daily Volume: 4,346,500
Last Update: 05/21/13 - 4:00 PM EDT
Volume: 3,487,807
YTD Performance: 22.54%
Open: $102.45
Previous Close: $102.18
52 Week Range: $67.61 - $114.95
Oustanding Shares: 749,976,556
Market Cap: 79,220,023,610
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 12 12 12
Moderate Buy 0 0 1 1
Hold 13 13 13 13
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.04 2.04 2.04
Latest Dividend: 0.47
Latest Dividend Yield: 1.78%
Dividend Ex-Date: 05/14/13
Price Earnings Ratio: 17.84
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
17.84 17.90 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
26.34% 44.85% 92.72%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.80 0.18 0.06
Net Income 0.00 0.00 0.00
EPS 36.60 0.24 0.07
Earnings for AMGN:
EBITDA 6.96B
Revenue 17.27B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.68 $1.73 $7.19 $8.31
Number of Analysts 4 4 4 4
High Estimate $1.71 $1.80 $7.25 $8.74
Low Estimate $1.65 $1.70 $7.16 $7.80
Prior Year $1.82 $1.67 $6.45 $7.19
Growth Rate (Year over Year) -7.83% 3.44% 11.51% 15.47%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
JOHNDHasseyJr: RT @NASDAQ: NASDAQ-100 AHI at 2982.57 (up 0.02%) movers: $FFIV, $DTV, $NVDA, $AMGN, $FB http://t.co/3xWOe5qVgh #nasdaq
1 hour ago from Twitter for iPhone
SwingTradeAlert: $AMGN Regaining key support + 50DMA Looks good here. http://t.co/mZX9o28kgv
1 hour ago from StockTwits Web
tradingview: $AMGN chart by beanz744: http://t.co/gyuZd5hiod Need another couple bars to see.
1 hour ago from TradingView
DozenStocks: Top S&P100 #Stocks Performance $MDT $MRK $HD $AMGN $CMCSA $JPM $GILD $COST $WFC $GS $FDX $AXP $CVX $CVS more@ http://t.co/n4QZIDxy7w
5 hours ago from CJ AutoTweeter
DozenStocks: Top Nasdaq100 #Stocks Performance $SHLD $NUAN $CHRW $BIIB $VRTX $ALXN $ATVI $WDC $AMGN $AVGO $FAST $BBBY more@ http://t.co/YdSIjG11yN
5 hours ago from CJ AutoTweeter
DozenStocks: Top S&P500 #Stocks Performance $MDT $MRK $AZO $TDC $CHRW $BIIB $CVC $ALXN $HD $ACT $KSS $WDC $NUE $AMGN more@ http://t.co/RPeaHBZz9y
5 hours ago from CJ AutoTweeter
StockPlayer6: RT @CAMAR024: $XLV decent flag setup. like $BIIB for continuation and $AMGN for a bounce….$GILD could rip to 60
5 hours ago from web
CAMAR024: $XLV decent flag setup. like $BIIB for continuation and $AMGN for a bounce….$GILD could rip to 60
5 hours ago from Twitter for Mac
stockchartscom: Today's Top 5 Technical Gainers among S&P Stocks: $AZO, $MDT, $HD, $AMGN, $TE http://t.co/ctFzkw6tom #sccrankings #stockcharts
9 hours ago from StockCharts.com
HumbleBioTrader: RT @TraderInPlay: Pharma a top-performing $SPX sector on the day: $XLV $MRK $GILD $AMGN $BIIB
9 hours ago from web
By

Jim Cramer

 | May 7, 2013 | 6:53 AM EDT

I have always resolved it in a practical, but chicken, way.

By

Doug Kass

 | May 1, 2013 | 7:37 AM EDT
Let's take a peek and overnight and morning markets.

bullishAmgen upgraded at Goldman

May 1, 2013 | 7:29 AM EDT

AMGN was upgraded from Neutral to Buy, Goldman Sachs said. $130 price target. Company also added to the Conviction Buy List, as the company has mulitple potential catalysts. 

By

Helene Meisler

 | Apr 28, 2013 | 7:00 PM EDT

Yet the market refuses -- and sentiment is anything but giddy, even at these heights.

By

Scott Redler

 | Apr 24, 2013 | 6:50 PM EDT

Banks continued higher, basic materials outperformed.

By

Jim Cramer

 | Apr 24, 2013 | 1:16 PM EDT

It’s the only thing that explains today’s action.

By

Doug Kass

 | Apr 24, 2013 | 7:46 AM EDT
Here is what the analyst community is up to this morning.

bullishAmgen estimates increased at UBS

Apr 24, 2013 | 7:41 AM EDT

AMGN estimates were raised on improving operating expenses, despite the weak first quarter results, said UBS.

By

Doug Kass

 | Apr 24, 2013 | 7:21 AM EDT
Let's take a peek at the markets.
By

Doug Kass

 | Apr 23, 2013 | 4:59 PM EDT
It guides to a very weak third quarter.

NetApp (NTAP): Storing Up Disappointment

By

Chris Laudani

 | May 21, 2013 | 5:33 PM EDT
Co misses on revenues. Revenue rose (if you can call it that) 0.8% to $1.7 bin. (I was looking for 1.7% y/y rev growth.)...

Making a late move on NTAP

By

Robert Lang

 | May 21, 2013 | 3:46 PM EDT
We added a call spread for NTAP here, not as pricey as the move implies, the chart not looking too bad. I like this for...

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.